Back to Health Equity Blog

SCOTUS Rebukes Challenge to Mifepristone’s Legality as a Safe Abortion Drug

Health Equity Blog. Health equity is a founding pillar of HLB. We're committed to equal access to health care for all.

On June 13, the U.S. Supreme Court released its decision in FDA v. Alliance for Hippocratic Medicine, overturning the opinions of the lower federal courts in the case that ruled mifepristone was unsafe. Since it was first approved by the FDA in 2000, mifepristone, commonly used in combination with misoprostol, is a widely accepted and commonly used oral abortion medication. As expected, the Court’s decision has either been heralded or lamented, depending upon which side of the abortion aisle one sits.